| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.804 | 3.742 | 4.123 | 7.679 | 2.295 | 1.867 | 16.304 | 19.217 | 20.882 |
| Total Income - EUR | 0 | 1.804 | 3.742 | 4.124 | 7.679 | 2.295 | 1.867 | 16.304 | 19.217 | 20.882 |
| Total Expenses - EUR | 1.499 | 1.217 | 3.658 | 6.232 | 3.632 | 1.331 | 654 | 3.901 | 14.992 | 12.708 |
| Gross Profit/Loss - EUR | -1.499 | 587 | 84 | -2.108 | 4.047 | 964 | 1.214 | 12.403 | 4.225 | 8.174 |
| Net Profit/Loss - EUR | -1.499 | 533 | -29 | -2.232 | 3.817 | 895 | 1.158 | 11.914 | 3.297 | 6.762 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Elyzema Prest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 169 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.619 | 3.269 | 3.733 | 1.893 | 2.750 | 3.353 | 782 | 12.074 | 4.179 | 8.823 |
| Inventories | 0 | 0 | 433 | 356 | 349 | 343 | 335 | 0 | 0 | 1.075 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 487 | 485 | 1.130 |
| Cash | 2.619 | 3.269 | 3.301 | 1.537 | 2.401 | 3.010 | 447 | 11.587 | 3.694 | 6.619 |
| Shareholders Funds | 2.677 | 3.183 | 3.100 | 812 | 2.505 | 3.353 | 777 | 11.965 | 3.348 | 6.813 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 42 | 43 | 42 | 42 |
| Debts | 110 | 136 | 633 | 1.081 | 244 | 0 | 5 | 108 | 830 | 2.010 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8121 - 8121" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Elyzema Prest Srl